Blastomycosis in patients with the acquired immunodeficiency syndrome.

PubWeight™: 1.09‹?› | Rank: Top 10%

🔗 View Article (PMID 1567099)

Published in Ann Intern Med on May 15, 1992

Authors

P G Pappas1, J C Pottage, W G Powderly, V J Fraser, C W Stratton, S McKenzie, M L Tapper, H Chmel, F C Bonebrake, R Blum

Author Affiliations

1: University of Alabama, School of Medicine, Birmingham.

Articles citing this

Clinical and laboratory update on blastomycosis. Clin Microbiol Rev (2010) 2.01

Transmission of tropical and geographically restricted infections during solid-organ transplantation. Clin Microbiol Rev (2008) 1.27

Endemic mycoses in AIDS: a clinical review. Clin Microbiol Rev (1995) 1.20

Emerging disease issues and fungal pathogens associated with HIV infection. Emerg Infect Dis (1996) 1.17

Antifungal prophylaxis during neutropenia and immunodeficiency. Clin Microbiol Rev (1997) 1.16

Immunogenicity and protective efficacy of the WI-1 adhesin of Blastomyces dermatitidis. Infect Immun (1998) 1.06

Genetic diversity in clinical isolates of the dimorphic fungus Blastomyces dermatitidis detected by a PCR-based random amplified polymorphic DNA assay. J Clin Microbiol (1995) 0.90

T-Cell epitopes and human leukocyte antigen restriction elements of an immunodominant antigen of Blastomyces dermatitidis. Infect Immun (2000) 0.87

Endemic mycosis complicating human immunodeficiency virus infection. West J Med (1996) 0.85

The endemic mimic: blastomycosis an illness often misdiagnosed. Trans Am Clin Climatol Assoc (2014) 0.80

Blastomycosis mortality rates, United States, 1990-2010. Emerg Infect Dis (2014) 0.79

Extracorporeal membrane oxygenation (ECMO) for severe acute respiratory distress syndrome (ARDS) in fulminant blastomycosis in Germany. BMJ Case Rep (2009) 0.77

Minimizing fungal disease deaths will allow the UNAIDS target of reducing annual AIDS deaths below 500 000 by 2020 to be realized. Philos Trans R Soc Lond B Biol Sci (2016) 0.75

Diagnostic dilemma of a young man with Fever and headaches. Neurohospitalist (2012) 0.75

Computed tomographic scan evaluation of pulmonary blastomycosis. Can J Infect Dis Med Microbiol (2009) 0.75

Primary cutaneous blastomycosis as a cause of acute respiratory distress syndrom: case report and literature review. J Clin Aesthet Dermatol (2009) 0.75

Approach to Fungal Infections in Human Immunodeficiency Virus-Infected Individuals: Pneumocystis and Beyond. Clin Chest Med (2017) 0.75

Articles by these authors

(truncated to the top 100)

The influence of inadequate antimicrobial treatment of bloodstream infections on patient outcomes in the ICU setting. Chest (2000) 9.51

Inadequate antimicrobial treatment of infections: a risk factor for hospital mortality among critically ill patients. Chest (1999) 7.40

Treatment of cryptococcal meningitis associated with the acquired immunodeficiency syndrome. National Institute of Allergy and Infectious Diseases Mycoses Study Group and AIDS Clinical Trials Group. N Engl J Med (1997) 5.88

Twice-daily compared with once-daily thoracic radiotherapy in limited small-cell lung cancer treated concurrently with cisplatin and etoposide. N Engl J Med (1999) 5.84

Comparison of amphotericin B with fluconazole in the treatment of acute AIDS-associated cryptococcal meningitis. The NIAID Mycoses Study Group and the AIDS Clinical Trials Group. N Engl J Med (1992) 5.84

Chlamydia pneumoniae infection of the central nervous system in multiple sclerosis. Ann Neurol (1999) 5.83

The safety and efficacy of zidovudine (AZT) in the treatment of subjects with mildly symptomatic human immunodeficiency virus type 1 (HIV) infection. A double-blind, placebo-controlled trial. The AIDS Clinical Trials Group. Ann Intern Med (1990) 5.55

Practice guidelines for the management of cryptococcal disease. Infectious Diseases Society of America. Clin Infect Dis (2000) 5.53

Serum dilution test for bactericidal activity. II. Standardization and correlation with antimicrobial assays and susceptibility tests. J Infect Dis (1977) 4.00

The relationship between suicide risk and sexual orientation: results of a population-based study. Am J Public Health (1998) 3.75

Mycobacterium avium-intracellulare: a cause of disseminated life-threatening infection in homosexuals and drug abusers. Ann Intern Med (1982) 3.58

Characterization of human bone marrow fibroblast colony-forming cells (CFU-F) and their progeny. Blood (1980) 3.51

Antibiotic resistance in the intensive care unit. Ann Intern Med (2001) 3.40

Accelerated bone mineral loss in HIV-infected patients receiving potent antiretroviral therapy. AIDS (2000) 3.39

Definition, assessment and treatment of wheezing disorders in preschool children: an evidence-based approach. Eur Respir J (2008) 3.36

Amphotericin B: current understanding of mechanisms of action. Antimicrob Agents Chemother (1990) 3.26

A controlled clinical trial of E5 murine monoclonal IgM antibody to endotoxin in the treatment of gram-negative sepsis. The XOMA Sepsis Study Group. JAMA (1991) 3.25

Serum dilution test for bactericidal activity. I. Selection of a physiologic diluent. J Infect Dis (1977) 3.15

Difficult/therapy-resistant asthma: the need for an integrated approach to define clinical phenotypes, evaluate risk factors, understand pathophysiology and find novel therapies. ERS Task Force on Difficult/Therapy-Resistant Asthma. European Respiratory Society. Eur Respir J (1999) 2.96

CSF oligoclonal bands in MS include antibodies against Chlamydophila antigens. Neurology (2001) 2.88

A preliminary study of ritonavir, an inhibitor of HIV-1 protease, to treat HIV-1 infection. N Engl J Med (1995) 2.88

Controlled evaluation of BACTEC Plus 26 and Roche Septi-Chek aerobic blood culture bottles. J Clin Microbiol (1991) 2.62

Demography of sexual orientation in adolescents. Pediatrics (1992) 2.61

Clinical and laboratory characteristics of Achromobacter xylosoxidans infection. J Clin Microbiol (1980) 2.43

An objective case definition of lipodystrophy in HIV-infected adults: a case-control study. Lancet (2003) 2.43

Opportunistic infection in previously healthy women. Initial manifestations of a community-acquired cellular immunodeficiency. Ann Intern Med (1982) 2.41

Detection of major histocompatibility complex class I-restricted, HIV-specific cytotoxic T lymphocytes in the blood of infected hemophiliacs. Blood (1989) 2.37

Experience with a clinical guideline for the treatment of ventilator-associated pneumonia. Crit Care Med (2001) 2.35

Pulmonary cryptococcosis in patients without HIV infection. Chest (1999) 2.31

Mechanical ventilation with or without 7-day circuit changes. A randomized controlled trial. Ann Intern Med (1995) 2.26

Influences on adolescents' decision to postpone onset of sexual intercourse: a survival analysis of virginity among youths aged 13 to 18 years. J Adolesc Health (2000) 2.25

Sex differences in nevirapine rash. Clin Infect Dis (2000) 2.09

Minimum inhibitory and bactericidal concentrations of 44 antimicrobial agents against three standard control strains in broth with and without human serum. Antimicrob Agents Chemother (1981) 2.04

Spontaneous bacterial peritonitis. A review of 28 cases with emphasis on improved survival and factors influencing prognosis. Am J Med (1978) 2.04

Results of a comprehensive infection control program for reducing surgical-site infections in coronary artery bypass surgery. Infect Control Hosp Epidemiol (1999) 2.03

Clarithromycin as monotherapy for eradication of Helicobacter pylori: a randomized, double-blind trial. Am J Gastroenterol (1993) 2.00

Controlled evaluation of the agar-slide and radiometric blood culture systems for the detection of bacteremia and fungemia. J Clin Microbiol (1986) 1.98

An expert system for culture-based infection control surveillance. Proc Annu Symp Comput Appl Med Care (1993) 1.98

Cough and asthma in children. Pediatr Ann (1996) 1.95

Controlled evaluation of BACTEC PLUS 27 and Roche Septi-Chek anaerobic blood culture bottles. J Clin Microbiol (1992) 1.92

Multicenter collaborative evaluation of a standardized serum bactericidal test as a prognostic indicator in infective endocarditis. Am J Med (1985) 1.92

A randomized trial of three antipneumocystis agents in patients with advanced human immunodeficiency virus infection. NIAID AIDS Clinical Trials Group. N Engl J Med (1995) 1.89

Central-nervous-system toxoplasmosis in homosexual men and parenteral drug abusers. Ann Intern Med (1984) 1.88

Antigenic specificity of antibody-dependent cell-mediated cytotoxicity directed against human immunodeficiency virus in antibody-positive sera. J Virol (1989) 1.87

The clinical and economic impact of deep chest surgical site infections following coronary artery bypass graft surgery. Chest (2000) 1.85

Differentiation of beta-lactamase variants of Staphylococcus aureus by substrate hydrolysis profiles. J Infect Dis (1989) 1.80

Bacteremia due to Pseudomonas aeruginosa complicating neoplastic disease: a progress report. J Infect Dis (1974) 1.80

Serum theophylline levels in asthmatic children after oral administration of two slow-release theophylline preparations. Arch Dis Child (1978) 1.79

Amphotericin B: delivery systems. Antimicrob Agents Chemother (1990) 1.78

Use of paromomycin for treatment of cryptosporidiosis in patients with AIDS. Clin Infect Dis (1993) 1.77

Correlation of serum bactericidal activity with antimicrobial agent level and minimal bactericidal concentration. J Infect Dis (1982) 1.74

Randomized study of brachytherapy in the initial management of patients with malignant astrocytoma. Int J Radiat Oncol Biol Phys (1998) 1.72

Invasive aspergillosis in renal transplant recipients: correlation with corticosteroid therapy. J Infect Dis (1983) 1.72

A prospective study of the ophthalmologic findings in the acquired immune deficiency syndrome. Am J Ophthalmol (1984) 1.70

Amphotericin B lipid complex compared with amphotericin B in the treatment of cryptococcal meningitis in patients with AIDS. Clin Infect Dis (1996) 1.68

Comparison of the Staph-Ident system with a conventional method for species identification of urine and blood isolates of coagulase-negative staphylococci. J Clin Microbiol (1983) 1.66

Serum levels of arabinitol in the detection of invasive candidiasis in animals and humans. J Infect Dis (1981) 1.65

Timing of events in normal swallowing: a videofluoroscopic study. Dysphagia (2000) 1.64

Effective treatment of multidrug-resistant enterococcal experimental endocarditis with combinations of cell wall-active agents. J Infect Dis (1996) 1.63

The impact of nosocomial infections on patient outcomes following cardiac surgery. Chest (1997) 1.62

Insulin resistance in HIV protease inhibitor-associated diabetes. J Acquir Immune Defic Syndr (1999) 1.61

Refractory mucosal candidiasis in patients with human immunodeficiency virus infection. Clin Infect Dis (1998) 1.60

Use of extracts versus whole-cell bacterial suspensions in the identification of Staphylococcus aureus beta-lactamase variants. Antimicrob Agents Chemother (1990) 1.59

Estimating the prevalence of chronic fatigue syndrome and associated symptoms in the community. Public Health Rep (1992) 1.59

Combination and monotherapy with zidovudine and zalcitabine in patients with advanced HIV disease. The NIAID AIDS Clinical Trials Group. Ann Intern Med (1995) 1.59

Comparative serological and cutaneous reactivity of candidal cytoplasmic proteins and mannan separated by affinity for concanavalin A. J Clin Microbiol (1977) 1.56

Seizure propensity with imipenem. Arch Intern Med (1989) 1.54

European AIDS Clinical Society (EACS) guidelines on the prevention and management of metabolic diseases in HIV. HIV Med (2008) 1.54

Rhino-orbital cerebral mucormycosis. Ear Nose Throat J (1990) 1.53

Antiviral chemoprophylaxis after occupational exposure to human immunodeficiency virus: why, when, where, and what. Am J Ophthalmol (1997) 1.52

Mannan mucin-1 peptide immunization: influence of cyclophosphamide and the route of injection. J Immunother (2001) 1.52

Cisplatin plus doxorubicin plus cyclophosphamide in metastatic or recurrent thymoma: final results of an intergroup trial. The Eastern Cooperative Oncology Group, Southwest Oncology Group, and Southeastern Cancer Study Group. J Clin Oncol (1994) 1.51

Opportunistic infection complicating acquired immune deficiency syndrome. Clinical features of 25 cases. Medicine (Baltimore) (1984) 1.51

Cytomegalovirus infection of the alimentary tract: a clinicopathological correlation. Am J Gastroenterol (1986) 1.51

The clinical spectrum of Campylobacter fetus infections: report of five cases and review of the literature. Q J Med (1980) 1.50

The occurrence of ventilator-associated pneumonia in a community hospital: risk factors and clinical outcomes. Chest (2001) 1.48

Bacteremia in hospitalized patients infected with the human immunodeficiency virus: a case-control study of risk factors and outcome. J Acquir Immune Defic Syndr Hum Retrovirol (1995) 1.47

Vibrio alginolyticus infections in humans. J Clin Microbiol (1979) 1.47

Candida krusei fungemia. Report of 4 cases and review of the literature. Medicine (Baltimore) (1993) 1.44

European Epidemiologic Registry of Cystic Fibrosis (ERCF): comparison of major disease manifestations between patients with different classes of mutations. Pediatr Pulmonol (2001) 1.44

Clinical features of Pneumocystis pneumonia in the acquired immune deficiency syndrome. Am Rev Respir Dis (1984) 1.44

Improved lung function tests on changing from topical timolol: non-selective beta-blockade impairs lung function tests in elderly patients. Eye (Lond) (1993) 1.44

Corynebacterium equi infection complicating neoplastic disease. Am J Clin Pathol (1977) 1.43

Structural displacements in normal swallowing: a videofluoroscopic study. Dysphagia (2000) 1.43

Sexually transmitted disease acquisition among women infected with human immunodeficiency virus type 1. J Infect Dis (1998) 1.43

A clinical comparison of beclomethasone dipropionate delivered by pressurised aerosol and as a powder from a rotahaler. Arch Dis Child (1979) 1.41

Characterization of four beta-lactamases produced by Staphylococcus aureus. Antimicrob Agents Chemother (1992) 1.41

Progressive multifocal leukoencephalopathy in a male homosexual with T-cell immune deficiency. N Engl J Med (1982) 1.41

Renal disease in patients with AIDS: a clinicopathologic study. Clin Nephrol (1984) 1.40

Thermonuclease test for same-day identification of Staphylococcus aureus in blood cultures. J Clin Microbiol (1985) 1.40

The expanding horizons of infection control. Infect Control Hosp Epidemiol (1995) 1.39

Agminated atypical (dysplastic) nevi: case report and review of the literature. Arch Dermatol (2001) 1.38

Resistance to amphotericin B associated with defective sterol delta 8-->7 isomerase in a Cryptococcus neoformans strain from an AIDS patient. FEMS Microbiol Lett (1994) 1.38

Clindamycin elimination in patients with liver disease. J Antimicrob Chemother (1981) 1.38

Prophylaxis and treatment of opportunistic infection in patients on HAART. AIDS Read (2003) 1.38

Video teleconferencing with realistic simulation for medical education. J Clin Anesth (2000) 1.38

Salmonella oslo. A focal outbreak in a hospital. Am J Med (1976) 1.32

The impact of comorbidity on mortality following in-hospital diagnosis of tuberculosis. Chest (1998) 1.32

ESGE-ESGENA Guideline: cleaning and disinfection in gastrointestinal endoscopy. Endoscopy (2008) 1.30

Mucosal candidiasis caused by non-albicans species of Candida in HIV-positive patients. AIDS (1992) 1.29